Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -130,778 | N/A | N/A |
| Depreciation Amortization | 1,826 | N/A | N/A |
| Income taxes - deferred | -7,547 | N/A | N/A |
| Accounts payable and accrued liabilities | -421 | N/A | N/A |
| Other Working Capital | 10,512 | N/A | N/A |
| Other Operating Activity | 40,890 | 0 | 0 |
| Operating Cash Flow | $-85,518 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -26,124 | N/A | N/A |
| Net Acquisitions | -3,195 | N/A | N/A |
| Purchase Of Investment | -141,519 | N/A | N/A |
| Sale Of Investment | 82,977 | N/A | N/A |
| Investing Cash Flow | $-87,861 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 1 | N/A | N/A |
| Other Financing Activity | 223,739 | 0 | 0 |
| Financing Cash Flow | $223,740 | $N/A | $N/A |
| Beginning Cash Position | 31,446 | N/A | N/A |
| End Cash Position | 81,807 | N/A | N/A |
| Net Cash Flow | $50,361 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -85,518 | N/A | N/A |
| Capital Expenditure | -26,124 | N/A | N/A |
| Free Cash Flow | -111,642 | 0 | 0 |